Ultragenyx prices upsized IPO at $21, above the range – NASDAQ
|
Ultragenyx prices upsized IPO at $ 21, above the range
NASDAQ Ultragenyx Pharmaceutical, a clinical-stage biotech developing treatments for rare metabolic genetic diseases, raised $ 121 million by offering 5.8 million shares at $ 21, above the range of $ 19 to $ 20. Ultragenyx Pharmaceutical plans to list on the … |
